tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BMRN Stock Latest News

Buy Rating on BioMarin: Strong Early Voxzogo Data, Real‑World Durability, and Underpenetrated Achondroplasia Opportunity Drive Upside
RatingsBuy Rating on BioMarin: Strong Early Voxzogo Data, Real‑World Durability, and Underpenetrated Achondroplasia Opportunity Drive Upside
1d ago
BMRN
Wells Fargo says buy BioMarin shares amid Phase 2 trial discontinuation weakness
PremiumThe Fly
Wells Fargo says buy BioMarin shares amid Phase 2 trial discontinuation weakness
1d ago
BMRN
BioMarin Halts VOXZOGO Dosing in Select Phase 2 Trials
PremiumCompany Announcements
BioMarin Halts VOXZOGO Dosing in Select Phase 2 Trials
1d ago
8K
BMRN
BioMarin discontinues enrollment in some Phase 2 Voxzogo trials
PremiumThe Fly
BioMarin discontinues enrollment in some Phase 2 Voxzogo trials
1d ago
BMRN
BioMarin’s Voxzogo shows impact in pediatric achondroplasia
PremiumThe Fly
BioMarin’s Voxzogo shows impact in pediatric achondroplasia
5d ago
BMRN
BioMarin: Strategic Amicus Acquisition Supports Buy Rating Despite Voxzogo Assumption Reset
PremiumRatingsBioMarin: Strategic Amicus Acquisition Supports Buy Rating Despite Voxzogo Assumption Reset
6d ago
BMRN
BioMarin price target lowered to $85 from $97 at BofA
Premium
The Fly
BioMarin price target lowered to $85 from $97 at BofA
6d ago
BMRN
FOLD
BioMarin price target raised to $105 from $80 at Barclays
Premium
The Fly
BioMarin price target raised to $105 from $80 at Barclays
13d ago
BMRN
BioMarin price target raised to $105 from $80 at Barclays
PremiumThe Fly
BioMarin price target raised to $105 from $80 at Barclays
14d ago
BMRN
BioMarin announces U.S FDA approved sBLA for Palynziq
PremiumThe Fly
BioMarin announces U.S FDA approved sBLA for Palynziq
16d ago
BMRN
BioMarin price target raised to $104 from $98 at Canaccord
PremiumThe Fly
BioMarin price target raised to $104 from $98 at Canaccord
19d ago
BMRN
FOLD
BioMarin price target raised to $94 from $90 at Bernstein
PremiumThe Fly
BioMarin price target raised to $94 from $90 at Bernstein
20d ago
BMRN
BioMarin price target lowered to $86 from $106 at Guggenheim
PremiumThe FlyBioMarin price target lowered to $86 from $106 at Guggenheim
20d ago
BMRN
FOLD
BioMarin price target lowered to $55 from $60 at H.C. Wainwright
Premium
The Fly
BioMarin price target lowered to $55 from $60 at H.C. Wainwright
20d ago
BMRN
BioMarin Earnings Call Highlights Growth, Pipeline, Deals
Premium
Company Announcements
BioMarin Earnings Call Highlights Growth, Pipeline, Deals
21d ago
BMRN
BioMarin price target lowered to $95 from $98 at Oppenheimer
PremiumThe Fly
BioMarin price target lowered to $95 from $98 at Oppenheimer
21d ago
BMRN
FOLD
BioMarin price target lowered to $97 from $102 at BofA
PremiumThe Fly
BioMarin price target lowered to $97 from $102 at BofA
21d ago
BMRN
BioMarin: Strong Q4 Beat, Solid Multi‑Year Outlook, and Strategic Amicus Acquisition Support Buy Rating
PremiumRatings
BioMarin: Strong Q4 Beat, Solid Multi‑Year Outlook, and Strategic Amicus Acquisition Support Buy Rating
21d ago
BMRN
BioMarin: Competitive Voxzogo Headwinds Offset by Pipeline Upside and Undervalued Long‑Term Growth Potential
PremiumRatings
BioMarin: Competitive Voxzogo Headwinds Offset by Pipeline Upside and Undervalued Long‑Term Growth Potential
21d ago
BMRN
Balanced Risk-Reward Amid Evolving Growth Profile and Rising Competition at BioMarin
PremiumRatingsBalanced Risk-Reward Amid Evolving Growth Profile and Rising Competition at BioMarin
21d ago
BMRN
BioMarin reports Q4 non-GAAP EPS 46c, consensus 56c
Premium
The Fly
BioMarin reports Q4 non-GAAP EPS 46c, consensus 56c
22d ago
BMRN
BioMarin sees 2026 non-GAAP EPS $4.95-$5.15, consensus $5.33
Premium
The Fly
BioMarin sees 2026 non-GAAP EPS $4.95-$5.15, consensus $5.33
22d ago
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >